Literature DB >> 22125279

Serum DJ-1/PARK 7 is a potential biomarker of choroidal nevi transformation.

Manuel F Bande1, Maria Santiago, Maria Jose Blanco, Purificacion Mera, Carmela Capeans, Maria Xose Rodríguez-Alvarez, Maria Pardo, Antonio Piñeiro.   

Abstract

PURPOSE: There is substantial evidence that intraocular melanomas arise from benign nevi in the uveal tract. Previous studies performed by the authors revealed that uveal melanoma cells secrete the oncoprotein DJ-1/PARK7 into the extracellular environment and circulation. The aim of this study was to determine whether circulating DJ-1 serum levels correlate with known clinical risk factors of nevi growth.
METHODS: Standardized ultrasonography, optical coherence tomography, and eye fundus examinations were used to evaluate the clinical risk factors of nevi growth. These clinical risk factors (including nevi size, distance of margins to the optic disc, detection of acoustic hollowness, presence of ocular symptoms, orange pigment, subretinal fluid, and absence of drusen) were examined in 53 consecutive patients from January 2009 to February 2011. Serum levels of DJ-1/PARK7 in these patients and in healthy age- and sex-matched controls (n = 32) were analyzed using ELISA.
RESULTS: Within the choroidal nevi group, DJ-1 serum levels were higher in those with symptoms (P < 0.033), with a nevus thickness greater than 1.5 mm (P < 0.001), a large basal diameter greater than 8 mm (P < 0.001), and the presence of acoustic hollowness (P < 0.001), compared to those patients without these risk factors. Similar significant differences were found when these at risk nevi subgroups were compared to healthy persons.
CONCLUSIONS: Elevated serum levels of DJ-1 are associated with choroidal nevi transformation risk factors. Therefore, DJ-1 appears to be a promising factor for predicting the growth of choroidal nevi and may be a potential biomarker of malignancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22125279     DOI: 10.1167/iovs.11-7948

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  DJ-1 ameliorates ischemic cell death in vitro possibly via mitochondrial pathway.

Authors:  Yuji Kaneko; Hideki Shojo; Jack Burns; Meaghan Staples; Naoki Tajiri; Cesar V Borlongan
Journal:  Neurobiol Dis       Date:  2013-09-21       Impact factor: 5.996

Review 2.  Proteomics in uveal melanoma.

Authors:  Michael J Heiferman; Vinit B Mahajan; Prithvi Mruthyunjaya
Journal:  Curr Opin Ophthalmol       Date:  2022-01-31       Impact factor: 4.299

Review 3.  Proteomics of uveal melanoma: a minireview.

Authors:  Søren K O Abildgaard; Henrik Vorum
Journal:  J Oncol       Date:  2013-09-03       Impact factor: 4.375

4.  Oxygen-glucose-deprived rat primary neural cells exhibit DJ-1 translocation into healthy mitochondria: a potent stroke therapeutic target.

Authors:  Yuji Kaneko; Naoki Tajiri; Hideki Shojo; Cesar V Borlongan
Journal:  CNS Neurosci Ther       Date:  2013-12-30       Impact factor: 5.243

5.  Cyclosporine A Treatment Abrogates Ischemia-Induced Neuronal Cell Death by Preserving Mitochondrial Integrity through Upregulation of the Parkinson's Disease-Associated Protein DJ-1.

Authors:  Naoki Tajiri; Cesar V Borlongan; Yuji Kaneko
Journal:  CNS Neurosci Ther       Date:  2016-06-01       Impact factor: 5.243

6.  In-depth proteomic profiling of the uveal melanoma secretome.

Authors:  Martina Angi; Helen Kalirai; Samuel Prendergast; Deborah Simpson; Dean E Hammond; Michele C Madigan; Robert J Beynon; Sarah E Coupland
Journal:  Oncotarget       Date:  2016-08-02

Review 7.  Blood Biomarkers of Uveal Melanoma: Current Perspectives.

Authors:  Manuel F Bande Rodríguez; Beatriz Fernandez Marta; Nerea Lago Baameiro; Maria Santiago-Varela; Paula Silva-Rodríguez; María Jose Blanco-Teijeiro; Maria Pardo Perez; Antonio Piñeiro Ces
Journal:  Clin Ophthalmol       Date:  2020-01-20

8.  A Panel of Circulating MicroRNAs Detects Uveal Melanoma With High Precision.

Authors:  Mitchell S Stark; Elin S Gray; Timothy Isaacs; Fred K Chen; Michael Millward; Ashleigh McEvoy; Pauline Zaenker; Melanie Ziman; H Peter Soyer; William J Glasson; Sunil K Warrier; Andrew L Stark; Olivia J Rolfe; Jane M Palmer; Nicholas K Hayward
Journal:  Transl Vis Sci Technol       Date:  2019-11-14       Impact factor: 3.283

9.  DJ-1 Is Upregulated in Oral Squamous Cell Carcinoma and Promotes Oral Cancer Cell Proliferation and Invasion.

Authors:  Shuaimei Xu; Dandan Ma; Rui Zhuang; Wenjuan Sun; Ying Liu; Jun Wen; Li Cui
Journal:  J Cancer       Date:  2016-05-24       Impact factor: 4.207

Review 10.  DJ-1 in Ocular Diseases: A Review.

Authors:  Cong Liu; Xiufen Liu; Jing Qi; Om Prakash Pant; Cheng-Wei Lu; Jilong Hao
Journal:  Int J Med Sci       Date:  2018-02-12       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.